MA H 1325
in committeeAn Act to ensure access to generic medication
Massachusetts · 2025-2026 Regular Session (194th General Court) · lower
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did MA H 1325 pass?
Not yet. MA H 1325 is in committee and has not come to a final vote. Latest recorded action (2026-02-09): Accompanied a study order, see H4789
What is MA H 1325 about?
By Representative Silvia of Fall River, a petition (accompanied by bill, House, No. 1325) of Alan Silvia relative to access to generic medications. Financial Services.
Who sponsors MA H 1325?
Alan Silvia is the primary sponsor of MA H 1325.
Description
By Representative Silvia of Fall River, a petition (accompanied by bill, House, No. 1325) of Alan Silvia relative to access to generic medications. Financial Services.
- Introduced
- —
- Latest action
- 2026-02-09 — Accompanied a study order, see H4789
- Bill type
- bill
- Last updated
- —
Sponsors
- Alan Silviaprimary
Committees
Not provided by source.
Action timeline
Newest first
2026-02-09
Accompanied a study order, see H4789
2025-06-03
Hearing scheduled for 06/10/2025 from 10:30 AM-01:00 PM in A-2
2025-02-27
Senate concurred
2025-02-27
Referred to the committee on Financial Services
referral-committee
Versions
- Bill TextCompare
Documents
Votes
Not provided by source.
Related bills
- Replaces: HD 2356
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:22:56.590024Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MA&identifier=H 1325. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.